Bluefront Equity acquires Norwegian firm Redox

The GP is acquiring a 51.8% stake in the company, alongside its management. 

According to Finansavisen, the company has sales of around NOK 150m (€14.9m) and was estimated to be worth around NOK 130m (€12.9m).

The GP said in a statement that it had monitored Redox for several years.

The deal is the GP's first investment from its debut Bluefront Equity Fund, launched last year. The vehicle aims to invest in supplier companies that ensure increased traceability, better fish health and welfare, enhanced quality of the end-product, improved hygiene, and that contribute towards digitalising the seafood industry.

Company 
Founded in 2004 and based in Averoy, Redox is a manufacturer of machinery for the aquaculture industry. 

People 
Bluefront Equity – Kjetil Haga (partner). 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Nordics
• Industrials
• Norway
• Small-cap buyout